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Ugi	Multicomponent	Reaction	
André Boltjes, Haixia Liu, Haiping Liu, and Alexander Dömling*1
University of Groningen, Groningen Research Institute of Pharmacy, 
Department of Drug Design, A. Deusinglaan 1 9713 AV Groningen, The 
Netherlands. 
Checked by Emma L. Baker-Tripp and Neil K. Garg 
Procedure	
A. N-(2,2-Dimethoxyethyl)-N-(2-oxo-2-(phenethylamino)ethyl)cylcohexane-
carboxamide. Into a 500 mL 3-necked, round-bottomed flask, equipped with a
6 cm Teflon blade overhead stirrer (Note 1), a 60-mL pressure equalizing 
dropping funnel holding a nitrogen inlet and a thermocouple (Figure 1), is 
added a mixture of N-(phenethyl)formamide (7.46 g, 50 mmol) and
triethylamine (16.8 mL, 120 mmol 2.4 equiv) in dichloromethane (50 mL) 
(Note 2).  The solution is cooled to approximately –10 °C using an ethanol-
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Figure 1. Reaction set-up  
 
Triphosgene (5.94 g, 20 mmol, 0.4 equiv) (Note 4) in dichloromethane 
(20 mL) is added dropwise to the stirring (500 rpm) mixture via the 
dropping funnel over a period of 45 min (Note 5), resulting in a dark 
red/brown solution. The reaction mixture is stirred at –10 °C for an 
additional 30 min (Note 6) (Figure 2).  
 
          
Figure 2. Color changes as reaction progresses  
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A separate 50 mL round-bottomed flask, which is charged with a 
mixture of aminoacetaldehyde dimethyl acetal (5.52 g, 52.5 mmol, 
1.05 equiv) and paraformaldehyde (1.50 g, 50 mmol, 1 equiv) in 50 mL 
methanol, is equipped with an air condenser and heated to 80 °C in an oil 
bath with stirring until a clear solution developed. After allowing the 
solution to cool to room temperature, cyclohexanecarboxylic acid (6.72 g, 
52.5 mmol, 1.05 equiv) is added. The resulting solution is then added 
together with another 50 mL MeOH to the in situ formed isocyanide 
reaction mixture at –10 °C via cannula. The reaction mixture is left to warm 
to room temperature. The overhead mechanical stirrer and 60-mL pressure 
equalizing dropping funnel are replaced with red septa and a 2.5 cm Teflon 
stir bar (Figure 3).  
 
 
Figure 3. Post-reagent addition set-up 
 
After stirred at room temperature for 48 h (Note 7), the reaction mixture 
is transferred to a 1000 mL one-necked, round-bottomed flask, along with 
CH2Cl2 (100 mL) that is used to rinse the flask, and the solution is 
concentrated by rotary evaporation (40 °C, 7.5 mmHg) to remove the 
methanol. Then the mixture is redissolved in CH2Cl2 (50 mL) and 
transferred to a 250 mL separatory funnel, washed with water (3 x 50 mL), 
saturated NaHCO3 (3 x 50 mL), and dried over MgSO4 (10g). The drying 
agent is removed by filtration through a medium porosity 150 mL filter 
funnel (200 mmHg applied vacuum), and the resulting solution is collected 
into a 1000 mL round-bottomed flask, in which the solution is concentrated 
by rotary evaporation (40 °C, 7.5 mmHg) (Note 8). 
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      Figure 4.  Appearance of the Ugi product for checkers before and after 
solvent removal 
 
 The red/brown oil is purified by flash chromatography on silica using 
hexanes and ethyl acetate as the eluent (Note 9). The collected fractions are 
placed in a 1000-mL round-bottomed flask and then concentrated by rotary 
evaporation (40 °C, 7.5 mmHg) to yield a reddish-brown oil (picture above) 
which is then placed under high vacuum (45 °C, 0.2 mmHg) for 12 h (Note 
10) to afford 7.46 g (46%, >99% purity) of N-(2,2-dimethoxyethyl)-N-(2-oxo-
2-(phenethylamino)-ethyl)cylcohexanecarboxamide as a brown solid 





1. The Teflon blade overhead stirrer was purchased from Arrow 
Engineering Mixing Products, model #1750; 115 VAC 60 Hz. 
2. Reagents and solvents used in this preparation are commercially 
available and used without further purification, including solvents 
dichloromethane and methanol, which were purchased from Fisher 
Chemical. Triphosgene (98%) and aminoacetaldehyde dimethyl acetal 
(99%) from AK Scientific Inc., N-(phenethyl)formamide (97%), 
trimethylamine (≥99%), paraformaldehyde (95%) and cyclohexane 
carboxylic acid (≥98%) from Sigma Aldrich. 
3. In a 1L Dewar cooling bath 275 g ice and 150 g ethanol were used to 
obtain a temperature of approximately –10 °C for the duration of the 
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reaction. Checkers utilized the thermocouple in the ice/ethanol bath to 
accurately measure for the duration of the reaction.  
4. The solid reagent triphosgene is a less hazardous substitute for highly 
toxic gaseous phosgene, however should be handled very carefully. 
Triphosgene may be fatal if inhaled and causes burns by all exposure 
routes. This water-reactive substance liberates toxic gas upon exposure 
to water. Triphosgene is a lachrymator and can decompose violently at 
elevated temperatures. Triphosgene should be weighed out and the 
reaction should be performed in a well-ventilated fume hood.  
5. Faster addition or temperatures above 0 °C will reduce the yield 
dramatically. Submitters noted that color is a good indicator of proper 
addition speed: slightly yellow color is good, orange towards brown 
indicates too fast addition of triphosgene. 
6. The isocyanide intermediate Rf = 0.80 (1:1 Hexanes:EtOAc), checked by 
TLC EMD gel 60 F254 pre-coated plates (0.25 mm) (visualized with 
254 nm UV lamp),  appears nearly exclusively indicating consumption 
of the formamide (Figure 5). 
 
Figure 5. TLC analysis of isocyanide formation 
 
7. Not all reagents are fully consumed, but after 48 h no change in spot 
intensity, checked by TLC EMD gel 60 F254 pre-coated plates (0.25 mm) 
(visualized with 254 nm UV lamp), was observed.  
 
 
Figure 6. TLC analysis of multi-component reaction 
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8. The bulk of solvent should be removed; however, leaving a trace of 
solvent (~0.5 g) is actually beneficial in allowing the product to 
crystallize. The crystallization process requires time (up to 2 weeks). 
The submitters report a yield of 9.05 g crude product. The submitters 
then triturate the crude crystals with 10 mL cold Et2O, filtering through 
a P4 glass filter and washing with another 10 mL cold Et2O. Yields after 
drying (0.5 mbar) 7.56 g (40%) pure N-(2,2-dimethoxyethyl)-N-(2-oxo-2-
(phenethylamino)ethyl)cylcohexanecarb-oxamide as pale yellow 
crystals (Figure 7). 
 
 
Figure 7. Appearance of the Ugi product from submitters 
 
9. The column chromatography was run as follows: A flash column with 
an outer diameter of 8 cm and capacity of 2000 mL was charged with 
silica (Silicycle Siliaflash P60 particle size 0.040–0.063 mm purchased 
from Silicycle; used as received) using a wet-pack method (316 g of 
silica in 700 mL of 66% hexanes in ethyl acetate). This gave a silica bed 
of 16 cm in height. The crude mixture was then dissolved in 15 mL of 
66% hexanes in ethyl acetate and then loaded onto the silica using a 
pipette. Sand was then added to fill 2 cm above the silica.  An eluent 
mixture of 66% hexanes in ethyl acetate (1300 mL) was used initially, 
followed by 50% ethyl acetate in hexanes (2000 mL) and 100% ethyl 
acetate (3000 mL). The flow rate was approximately 66 mL/min and 30-
mL fractions were collected. Fractions 148–182 were then collected as 
the product fractions. 
10. The checkers found that ethyl acetate was difficult to remove. Placing 
the purified reddish-brown oil under high vacuum (45 °C, 0.2 mmHg) 
for 12 h was required to remove the ethyl acetate. 
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11. N-(2,2-Dimethoxyethyl)-N-(2-oxo-2-(phenethylamino)ethyl) cyclohex-
anecarboxamide: mp = 83.4–85.2 °C, Rf = 0.42 (100% EtOAc)  1H NMR 
(500 MHz, CDCl3) δ: 1.16–1.30 (m, 3H), 1.37–1.52 (m, 2H), 1.56–1.71 (m, 
2H), 1.71–1.82 (m, 2H), 2.24 (tt, J = 11.5, 3.4 Hz, 0.5H), 2.58 (tt, J = 11.5, 
3.4 Hz, 0.5H), 2.80 (dt, J = 20.6, 7.2 Hz, 2H), 3.33 (s, 3H), 3.37 (s, 3H), 3.42 
(app t, J = 4.8 Hz, 2H), 3.49 (q, J = 6.7 Hz, 1H), 3.55 (q, J = 6.8 Hz, 1H), 
3.98 (d, J = 6.5 Hz, 2H), 4.39 (t, J = 5.3 Hz, 0.5H), 4.57 (t, J = 5.1 Hz, 0.5H), 
6.41–6.50 (m, 0.5H), 6.94–7.00 (m, 0.5H), 7.16–7.25 (m, 3H), 7.27–7.32 (m, 
2H); 13C NMR (125 MHz, CDCl3) δ: 25.7, 25.8, 25.9, 29.4, 29.5, 35.7, 35.8, 
40.4, 40.6, 40.8, 41.2, 50.5, 51.6, 52.3, 54.2, 55.2, 55.6, 102.8, 103.6, 126.6, 
126.8, 128.7, 128.8, 128.9, 138.7, 138.9, 169.4, 169.7, 178.0, 178.2; IR (film): 
3301, 2929, 2854, 1627, 1544, 1451 cm-1. HRMS (ESI). [M + H]+ calcd. for 
C21H33O4N2: 377.2440. Found: 377.2408. The tertiary amide rotamers are 
clearly visible in the NMR spectrum and show a 1:1 ratio. The purity of 
the compound was determined using qNMR: 14.1 mg of the product are 
dissolved in 0.8 mL of CDCl3. 1,3,5-trimethoxybenzene, 10.2 mg (99%, 
purchased from Alfa Aesar and used as received), is added as the 
internal standard. 1H NMR (500 MHz, CDCl3) gave a product purity of 
99.2%. 





The procedures in Organic Syntheses are intended for use only by 
persons with proper training in experimental organic chemistry.  All 
hazardous materials should be handled using the standard procedures for 
work with chemicals described in references such as "Prudent Practices in 
the Laboratory" (The National Academies Press, Washington, D.C., 2011; 
the full text can be accessed free of charge at 
http://www.nap.edu/catalog.php?record_id=12654).  All chemical waste 
should be disposed of in accordance with local regulations.  For general 
guidelines for the management of chemical waste, see Chapter 8 of Prudent 
Practices.  
In some articles in Organic Syntheses, chemical-specific hazards are 
highlighted in red “Caution Notes” within a procedure.  It is important to 
recognize that the absence of a caution note does not imply that no 
significant hazards are associated with the chemicals involved in that 
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procedure.  Prior to performing a reaction, a thorough risk assessment 
should be carried out that includes a review of the potential hazards 
associated with each chemical and experimental operation on the scale that 
is planned for the procedure.  Guidelines for carrying out a risk assessment 
and for analyzing the hazards associated with chemicals can be found in 
Chapter 4 of Prudent Practices. 
The procedures described in Organic Syntheses are provided as 
published and are conducted at one's own risk.  Organic Syntheses, Inc., its 
Editors, and its Board of Directors do not warrant or guarantee the safety of 
individuals using these procedures and hereby disclaim any liability for any 
injuries or damages claimed to have resulted from or related in any way to 





The Ugi multicomponent reaction of amines, oxo components, 
isocyanides and inorganic or organic acids leads to different scaffold types 
dependent on the nature of the acid component.2 For example carboxylic 
acids yield α-amino acylamides (Table 1). The Ugi multicomponent reaction 
is gaining increasing attention due to the rapid and convergent assembly of 
functional structures based on four classes of widely available starting 
material classes.3 In addition, our recent work on generating the isonitrile in 
situ is making the Ugi reaction even more attractive, as the isolation of the 
infamous isonitrile is circumvented in this methodology.4 While several 
approaches towards α-amino acylamides are possible, the Ugi approach is 
faster and moreover impresses by a very large substrate scope.5 Here the 
Ugi intermediate to the schistosomiasis drug praziquantel (PQZ, 2-
(cyclohexanecarbonyl)-2,3,6,7-tetrahydro-1H-pirazino[2,1-a]isoquinolin-
4(11bH)-one) is prepared to exemplify the usefulness of this methodology. It 
comprises a one-pot synthesis from the readily available bulk starting 
materials, 2-phenylethyl formamide, formaldehyde, cyclohexancarboxylic 
acid and aminoacetaldehyde dimethylacetal. N-Phenethylformamide reacts 
with triphosgene, which in turn reacts with paraformaldehyde, 
aminoacetaldehyde dimethylacetal, and cyclohexylcarboxylic acid in an Ugi 
four component reaction to the advanced praziquantel precursor in 46% 
yield.7 Many similar derivatives have been synthesized accordingly (Table 
1). 7 
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Table 1. Examples of Ugi products and their yields 
 aThe yields described are calculated from the combined yields over the 
two subsequent Ugi and Pictet-Spengler reaction steps, as the crude Ugi 
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Aminoacetaldehyde dimethyl acetal; (22483-09-6) 
Cyclohexane carboxylic acid; (98-89-5) 
N-(2,2-Dimethoxyethyl)-N-(2-oxo-2-
(Phenethylamino)ethyl)cylcohexanecarboxamide; (90142-13-5) 
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NAME         ELB-7-189p
EXPNO 3
PROCNO 1
F2 - Acquisition Parameters
Date_          20170123
Time              10.27
INSTRUM           av500
PROBHD   5 mm DCH 13C-1
PULPROG            zg30
TD 65536
SOLVENT           CDCl3
NS 8
DS 0
SWH           10000.000 Hz
FIDRES         0.152588 Hz





D1           2.00000000 sec
TD0 1
======== CHANNEL f1 ========
SFO1        500.1330008 MHz
NUC1 1H
P1 10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI 65536
SF          500.1300122 MHz
WDW EM
SSB      0
LB 0.30 Hz























































































































NAME         ELB-7-189p
EXPNO                10
PROCNO                1
F2 - Acquisition Parameters
Date_          20170126
Time               9.02
INSTRUM           av500
PROBHD   5 mm DCH 13C-1
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                   77
DS                    2
SWH           31250.000 Hz
FIDRES         0.476837 Hz
AQ            1.0485760 sec
RG               204.54
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        125.7722511 MHz
NUC1                13C
P1                 9.63 usec
PLW1        23.00000000 W
======== CHANNEL f2 ========
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.13500001 W
F2 - Processing parameters
SI               131072
SF          125.7577737 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0


























































































































































































NAME         ELB-8-029p
EXPNO 20
PROCNO 1
F2 - Acquisition Parameters
Date_          20170502
Time 14.06 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD 65536
SOLVENT           CDCl3
NS 8
DS 0
SWH           10000.000 Hz
FIDRES         0.305176 Hz





D1           2.00000000 sec
TD0 1
SFO1        500.1330008 MHz
NUC1 1H
P1 10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI 65536
SF          500.1300146 MHz
WDW EM
SSB      0
LB 0.30 Hz
GB       0
PC 1.00
N-(2,2-dimethoxyethyl)-N-(2-oxo-2-(phenethylamino)ethyl)cyclohexanecarboxamide
